Woon-Tae Jung1, Mei-Shu Li, Ajay Goel, C Richard Boland. 1. Division of Gastroenterology, Department of Internal Medicine, The Charles A Sammons Cancer Center, and the Baylor Research Institute, Baylor University Medical Center, Dallas, TX 75246, USA.
Abstract
BACKGROUND: JC virus (JCV) has been implicated in the pathogenesis of colorectal cancer; however, its role in premalignant lesions is unknown. The hypothesis that JCV DNA sequences and T-antigen (T-Ag) expression may be present in adenomatous polyps of the colon was tested. Furthermore, an association between JCV and microsatellite instability (MSI) was also sought in these lesions. METHODS: DNA was extracted from 74 paraffin-embedded adenomatous polyps. JCV gene sequences were amplified by polymerase chain reaction (PCR), and the specificity confirmed by DNA sequencing. Immunohistochemical staining was performed to localize T-Ag expression in the adenomas using a monoclonal antibody. For microsatellite instability analysis, 5 mononucleotide repeat markers (BAT-25, BAT-26, NR-21, NR-24, and NR-27) were coamplified in a pentaplex PCR and analyzed for deletion mutations. RESULTS: JCV T-Ag sequences were found in 82% (61 of 74) of adenomas, and T-Ag protein was expressed in 16% (12 of 74) of these polyps. The T-Ag staining was localized exclusively in the nuclei of adenoma cells, but never in the cytoplasm or the adjacent nonneoplastic cells. The prevalence of MSI-H and non-MSI-H (MSI-L/MSS) in adenomatous polyps was 9.5% (7 of 74) and 90.5% (67 of 74), respectively. Among the 61 adenomas that harbored JCV sequences, 8% (5 of 61) were MSI-H, and similarly among 12 adenomatous polyps expressing T-Ag protein 8% (1 of 12) of the adenomatous polyps were MSI-H. CONCLUSIONS: JCV T-Ag DNA sequences are frequently present in adenomatous polyps of the colon, and T-Ag is expressed specifically in the nuclei of these premalignant lesions. This study indicates that JCV T-Ag is present in the early stage of colonic carcinogenesis. Future studies will be required to determine the molecular mechanism of carcinogenesis in these JCV-infected lesions.
BACKGROUND:JC virus (JCV) has been implicated in the pathogenesis of colorectal cancer; however, its role in premalignant lesions is unknown. The hypothesis that JCV DNA sequences and T-antigen (T-Ag) expression may be present in adenomatous polyps of the colon was tested. Furthermore, an association between JCV and microsatellite instability (MSI) was also sought in these lesions. METHODS: DNA was extracted from 74 paraffin-embedded adenomatous polyps. JCV gene sequences were amplified by polymerase chain reaction (PCR), and the specificity confirmed by DNA sequencing. Immunohistochemical staining was performed to localize T-Ag expression in the adenomas using a monoclonal antibody. For microsatellite instability analysis, 5 mononucleotide repeat markers (BAT-25, BAT-26, NR-21, NR-24, and NR-27) were coamplified in a pentaplex PCR and analyzed for deletion mutations. RESULTS:JCV T-Ag sequences were found in 82% (61 of 74) of adenomas, and T-Ag protein was expressed in 16% (12 of 74) of these polyps. The T-Ag staining was localized exclusively in the nuclei of adenoma cells, but never in the cytoplasm or the adjacent nonneoplastic cells. The prevalence of MSI-H and non-MSI-H (MSI-L/MSS) in adenomatous polyps was 9.5% (7 of 74) and 90.5% (67 of 74), respectively. Among the 61 adenomas that harbored JCV sequences, 8% (5 of 61) were MSI-H, and similarly among 12 adenomatous polyps expressing T-Ag protein 8% (1 of 12) of the adenomatous polyps were MSI-H. CONCLUSIONS:JCV T-Ag DNA sequences are frequently present in adenomatous polyps of the colon, and T-Ag is expressed specifically in the nuclei of these premalignant lesions. This study indicates that JCV T-Ag is present in the early stage of colonic carcinogenesis. Future studies will be required to determine the molecular mechanism of carcinogenesis in these JCV-infected lesions.
Authors: L Del Valle; J Gordon; M Assimakopoulou; S Enam; J F Geddes; J N Varakis; C D Katsetos; S Croul; K Khalili Journal: Cancer Res Date: 2001-05-15 Impact factor: 12.701
Authors: R Gryfe; H Kim; E T Hsieh; M D Aronson; E J Holowaty; S B Bull; M Redston; S Gallinger Journal: N Engl J Med Date: 2000-01-13 Impact factor: 91.245
Authors: J Young; L A Simms; K G Biden; C Wynter; V Whitehall; R Karamatic; J George; J Goldblatt; I Walpole; S A Robin; M M Borten; R Stitz; J Searle; D McKeone; L Fraser; D R Purdie; K Podger; R Price; R Buttenshaw; M D Walsh; M Barker; B A Leggett; J R Jass Journal: Am J Pathol Date: 2001-12 Impact factor: 4.307
Authors: L Ricciardiello; L Laghi; P Ramamirtham; C L Chang; D K Chang; A E Randolph; C R Boland Journal: Gastroenterology Date: 2000-11 Impact factor: 22.682
Authors: Shalaka S Hampras; Raphael P Viscidi; Kathy J Helzlsouer; Ji-Hyun Lee; William J Fulp; Anna R Giuliano; Elizabeth A Platz; Dana E Rollison Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-08-15 Impact factor: 4.254
Authors: Sang Su Lee; Woon Tae Jung; Cha Young Kim; Chang Yoon Ha; Hyun Ju Min; Hyun Jin Kim; Tae Hyo Kim Journal: J Korean Soc Coloproctol Date: 2011-10-31
Authors: Sonia Ramamoorthy; Bikash Devaraj; Katsumi Miyai; Linda Luo; Yu-Tsueng Liu; C Richard Boland; Ajay Goel; John M Carethers Journal: Cancer Date: 2010-12-14 Impact factor: 6.860
Authors: Michael Selgrad; Jan Jacob Koornstra; Lucia Fini; Marloes Blom; Rong Huang; Edward B Devol; Wytske Boersma-van Ek; Gerard Dijkstra; Robert C Verdonk; Steven de Jong; Ajay Goel; Sharenda L Williams; Richard L Meyer; Elizabeth B Haagsma; Luigi Ricciardiello; C Richard Boland Journal: Clin Cancer Res Date: 2008-10-15 Impact factor: 12.531
Authors: Dana E Rollison; Kathy J Helzlsouer; Ji-Hyun Lee; William Fulp; Sandra Clipp; Judy A Hoffman-Bolton; Anna R Giuliano; Elizabeth A Platz; Raphael P Viscidi Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-04-21 Impact factor: 4.254